A cancer diagnosis of a loved one presents many challenges, both for the person coping with cancer and for his or her caregivers. There are many ways to help and support a loved one going through this difficult time. Read our post for some helpful tips from CancerCare.org.
A recent study published in the journal Cancer Epidemiology, Biomarkers & Prevention found that physical activity improves survival rates for men with localized prostate cancer.
April 13th is the start of National Oral, Head and Neck Cancer Awareness Week, a week-long observance that focuses on promoting education and awareness around the different types of cancers of the head, neck and mouth.
Prostate cancer incidence among distant relatives on both sides of a man’s family can help predict whether he will develop the disease, according to a recent study published in the journal Prostate.
While smoking is one of the main contributing factors to a lung cancer diagnosis, non-smokers can still be at risk. The American Cancer Society estimates that 10 to 15 percent of lung cancer patients in the U.S. have never smoked.
View our presentation to learn about the main risk factors for prostate cancer and lifestyle tips that may help lower your risk.
If you or a loved one is preparing to undergo cancer treatment and have been presented with various treatment options, one of the many medical terms you may have heard is "local control." Read this post to learn about this treatment term and what it means.
A new clinical trial recently reported in the Journal of Clinical Oncology found that combining stereotactic body radiation therapy (SBRT) with chemotherapy improved survival rates among 24 stage IV lung cancer patients.
According to the American Cancer Society, more than 61,500 new cases of kidney cancer are expected in 2015. In recognition of National Kidney Cancer Awareness Month, Columbus CyberKnife encourages patients and their loved ones to learn about the disease and treatment options.
Results from a recent study completed by a team of researchers affiliated with the University of Pittsburgh Cancer Institute provides rationale for a national clinical trial to assess the effectiveness of adding head and neck screening to lung cancer screening programs.